Observational studyDer Nervenarzt2023

[Over one year of B‑cell targeted therapy with Ofatumumab s.c.: first results of a prospective, patient-centered real-world observational study].

Rafael Klimas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.